Anti-rejection drugs

Anti-rejection drugs are medications given to organ transplant recipients to prevent their immune system from attacking and rejecting the new organ. Since the immune system naturally identifies foreign tissue as a threat, these drugs suppress or modulate immune responses to ensure the transplanted organ functions correctly. They are crucial for the longevity of the transplant but may increase infection risk. Common anti-rejection drugs include corticosteroids, calcineurin inhibitors, and antimetabolites. The treatment plan is carefully tailored, balancing preventing rejection while minimizing side effects, under close medical supervision.